Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Collaborative Molecular Epidemiology Study of Metabolic Dysregulation, DNA Methylation, and Breast Cancer Risk Among Nigerian Women: MEND Study Objectives and Design.

Tomi Akinyemiju | Omolola Salako | Adetola Daramola | Olusegun Alatise | Adewale Adeniyi | Gabriel Ogun | Omobolaji Ayandipo | Thomas Olajide | Olalekan Olasehinde | Olukayode Arowolo | Adewale Adisa | Oludolapo Afuwape | Aralola Olusanya | Aderemi Adegoke | Akinlolu Ojo | Trygve Tollefsbol | Donna Arnett
Journal of global oncology | 2019

To elucidate the role of metabolic dysregulation and associated DNA methylation changes on breast cancer risk and aggressive subtypes among Nigerian women. We describe the design and methods of a collaborative molecular epidemiology study of breast cancer in Nigerian hospitals.

Pubmed ID: 31194608

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: FIC NIH HHS, United States
    Id: K01 TW010271
  • Agency: NCI NIH HHS, United States
    Id: R01 CA204346
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK079626
  • Agency: NCI NIH HHS, United States
    Id: P30 CA013148
  • Agency: NCI NIH HHS, United States
    Id: R01 CA178441

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


QIAGEN (tool)

RRID:SCR_008539

A commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

View all literature mentions